Global Wealth Management Investment Advisory’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20
Closed -$2.63K 166
2023
Q4
$2.63K Hold
20
﹤0.01% 380
2023
Q3
$2.64K Hold
20
﹤0.01% 367
2023
Q2
$2.79K Buy
+20
New +$2.94K ﹤0.01% 371
2022
Q3
Sell
-32
Closed -$4K 166
2022
Q2
$4K Sell
32
-49
-60% -$6.43K ﹤0.01% 351
2022
Q1
$11K Sell
81
-16,696
-100% -$2M ﹤0.01% 307
2021
Q4
$1.96M Buy
16,777
+508
+3% +$59.8K 0.59% 59
2021
Q3
$1.95M Buy
16,269
+485
+3% +$56.5K 0.62% 57
2021
Q2
$1.89M Buy
15,784
+469
+3% +$51.5K 0.63% 57
2021
Q1
$1.52M Buy
15,315
+16
+0.1% +$1.61K 0.55% 66
2020
Q4
$1.53M Buy
15,299
+463
+3% +$49K 0.59% 63
2020
Q3
$1.63M Sell
14,836
-558
-4% -$62.1K 0.7% 53
2020
Q2
$1.63M Buy
15,394
+578
+4% +$59.7K 0.7% 54
2020
Q1
$1.32M Sell
14,816
-5,128
-26% -$483K 0.67% 57
2019
Q4
$1.99M Sell
19,944
-1,938
-9% -$182K 0.84% 51
2019
Q3
$1.95M Buy
21,882
+932
+4% +$80.8K 0.89% 42
2019
Q2
$1.73M Buy
20,950
+2,660
+15% +$209K 0.84% 45
2019
Q1
$1.48M Sell
18,290
-1,047
-5% -$82.5K 0.77% 50
2018
Q4
$1.47M Buy
+19,337
New +$1.51M 0.85% 47

Other funds holding AZN

Global Wealth Management Investment Advisory's AZN Position: Q1 2024 in Review

Global Wealth Management Investment Advisory sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 20 shares — an estimated $2.63K sold.

Global Wealth Management Investment Advisory first reported a position in AZN in Q4 2018 and held it in 18 quarters. The position peaked at $1.99M in Q4 2019. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Global Wealth Management Investment Advisory reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 20 AstraZeneca shares in Q1 2024, an estimated $2.63K.
  • Global Wealth Management Investment Advisory first reported a position in AstraZeneca in Q4 2018 and held it in 18 quarters.
  • Global Wealth Management Investment Advisory's AstraZeneca position peaked at $1.99M in Q4 2019.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2024, filed 10 May 2024.